|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 5 597-606, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
JC Engel, PS Doyle, J Palmer, I Hsieh, DF Bainton and JH McKerrow
Department of Pathology, University of California, San Francisco, California 94143, USA. jcengel@itsa.ucsf.edu
Cruzain, the major cysteine protease of the protozoan parasite Trypanosoma cruzi, is a target of rational drug design for chemotherapy of Chagas' disease. The precise biological role of cruzain in the parasite life cycle and the mechanism involved in the trypanocidal effect of cysteine protease inhibitors are still unclear. Here we report biological and ultrastructural alterations caused by cysteine protease inhibitors in T. cruzi epimastigotes. Cruzain, a glycoprotein that transits the Golgi-endosomal pathway, localized to pre-lysosomes/lysosomes in the posterior end of untreated epimastigotes by fluorescent microscopy utilizing either a biotinylated cysteine protease inhibitor to tag the active site, or a specific anti-cruzain antibody. Radiolabeled or biotinylated cysteine protease inhibitors bound exclusively to cruzain in intact epimastigotes confirming that cruzain is accessible to, and is targeted by the inhibitors. Treatment of T. cruzi epimastigotes with specific cysteine protease inhibitors arrested growth, altered the intracellular localization of cruzain, and induced major alterations in the Golgi complex. Following treatment, cruzain accumulated in peripheral dilations of Golgi cisternae. There was a concomitant 70% reduction in gold-labeled cruzain transported to lysosomes. Cisternae abnormalities in the Golgi compartment were followed by distention of ER and nuclear membranes. Brefeldin A increased the number and size of cisternae in epimastigotes. Pre-treatment of epimastigotes with cysteine protease inhibitors followed by exposure to brefeldin A induced a more rapid appearance of the cysteine protease inhibitor-induced Golgi alterations. Our results suggest that cysteine protease inhibitors prevent the normal autocatalytic processing and trafficking of cruzain within the Golgi apparatus. Accumulation of cruzain may decrease mobility of Golgi membranes and result in peripheral distention of cisternae. These major alterations of the Golgi complex parallel the death of T. cruzi epimastigotes.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  P. S. Doyle, Y. M. Zhou, J. C. Engel, and J. H. McKerrow A Cysteine Protease Inhibitor Cures Chagas' Disease in an Immunodeficient-Mouse Model of Infection Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3932 - 3939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Santos, C. Sant'Anna, A. Terres, N. L. Cunha-e-Silva, J. Scharfstein, and A. P. C. de A. Lima Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells J. Cell Sci., March 1, 2005; 118(5): 901 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nowak, H. Lotter, E. Tannich, and I. Bruchhaus Resistance of Entamoeba histolytica to the Cysteine Proteinase Inhibitor E64 Is Associated with Secretion of Pro-enzymes and Reduced Pathogenicity J. Biol. Chem., September 10, 2004; 279(37): 38260 - 38266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. McConville, K. A. Mullin, S. C. Ilgoutz, and R. D. Teasdale Secretory Pathway of Trypanosomatid Parasites Microbiol. Mol. Biol. Rev., March 1, 2002; 66(1): 122 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. S. Monteiro, M. Abrahamson, A. P. C. A. Lima, M. A. Vannier-Santos, and J. Scharfstein Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi J. Cell Sci., January 11, 2001; 114(21): 3933 - 3942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Que and S. L. Reed Cysteine Proteinases and the Pathogenesis of Amebiasis Clin. Microbiol. Rev., April 1, 2000; 13(2): 196 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Brooks, L Tetley, G. Coombs, and J. Mottram Processing and trafficking of cysteine proteases in Leishmania mexicana J. Cell Sci., January 11, 2000; 113(22): 4035 - 4041. [Abstract] [PDF]
|
|
|
|
|
|
J. Engel, C. Garcia, I Hsieh, P. Doyle, and J. McKerrow Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi J. Cell Sci., January 4, 2000; 113(8): 1345 - 1354. [Abstract] [PDF]
|
|
|
|
 |
|
 P. M. Selzer, S. Pingel, I. Hsieh, B. Ugele, V. J. Chan, J. C. Engel, M. Bogyo, D. G. Russell, J. A. Sakanari, and J. H. McKerrow Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target PNAS, September 28, 1999; 96(20): 11015 - 11022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Huete-Perez, J. C. Engel, L. S. Brinen, J. C. Mottram, and J. H. McKerrow Protease Trafficking in Two Primitive Eukaryotes Is Mediated by a Prodomain Protein Motif J. Biol. Chem., June 4, 1999; 274(23): 16249 - 16256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Engel, P. S. Doyle, I. Hsieh, and J. H. McKerrow Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection J. Exp. Med., August 17, 1998; 188(4): 725 - 734. [Abstract] [Full Text] [PDF]
|
|
